Ignite Creation Date:
2024-05-06 @ 11:21 AM
Last Modification Date:
2024-10-26 @ 12:44 PM
Study NCT ID:
NCT03498417
Status:
COMPLETED
Last Update Posted:
2018-07-30
First Post:
2018-03-30
Brief Title:
Anti-insulin-like Growth Factor-1 Receptor IGF-1R Antibodies in Graves Disease and Graves Orbitopathy
Sponsor:
University of Pisa
Organization:
University of Pisa
Study Overview
Official Title:
Serum Antibodies Against the Insulin-like Growth Factor-1 Receptor IGF-1R in Graves Disease and Graves Orbitopathy
Status:
COMPLETED
Status Verified Date:
2018-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
IGF1RAbsGO
Brief Summary:
The study is aimed at assessing IGF-1R-Abs in patients with Graves disease with or without GO compared with healthy subjects and patients with autoimmune thyroiditis in a cross-sectional investigation
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None